Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
作者信息
Sharma S C, Osborne R P, Jose B, Carlson J A
出版信息
Health Phys. 1984 Sep;47(3):452-4.
PMID:6500947
Abstract
摘要
相似文献
1
2
Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer.
Am J Obstet Gynecol. 1983 Dec 1;147(7):840-1. doi: 10.1016/0002-9378(83)90054-6.
3
Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.腹腔内注射放射性磷酸铬（P32）治疗卵巢癌。
J Med Assoc Ga. 1984 Jan;73(1):21-5.
4
Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
Gynecol Oncol. 1989 Mar;32(3):314-8. doi: 10.1016/0090-8258(89)90631-8.
5
Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.注射体积对腹腔内注射³²P的组织剂量、剂量率及治疗潜力的影响
Radiology. 1981 Oct;141(1):193-9. doi: 10.1148/radiology.141.1.7291525.
6
[Intraperitoneal irradiation in limited epithelial neoplasms of the ovary. Review of the literature].
Minerva Ginecol. 1985 Jul-Aug;37(7-8):407-13.
7
Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
South Med J. 1987 Dec;80(12):1513-7. doi: 10.1097/00007611-198712000-00007.
8
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
Int J Radiat Oncol Biol Phys. 1991 May;20(5):939-44. doi: 10.1016/0360-3016(91)90189-b.
9
Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
Am J Clin Oncol. 1988 Oct;11(5):515-9. doi: 10.1097/00000421-198810000-00001.
10
Adjuvant internal hepatic radiotherapy using colloidal 32P chromic phosphate in colorectal cancer.使用磷酸铬胶体32P进行辅助性肝内放射治疗在结直肠癌中的应用
Radiat Med. 1990 Nov-Dec;8(6):246-9.
Zotero 插件